maye gurbin kwayoyin halitta maganin cutar kansar huhun kusa da ni

maye gurbin kwayoyin halitta maganin cutar kansar huhun kusa da ni

Maganin Ciwon Huhu Na Halitta Kusa da Ni

Nemo maganin da ya dace don maye gurbi na huhu ciwon daji na iya zama mai ban mamaki. Wannan cikakken jagorar yana taimaka muku fahimtar zaɓuɓɓukanku da gano kulawa ta musamman kusa da ku. Za mu bincika hanyoyi daban-daban na jiyya waɗanda aka keɓance ga takamaiman maye gurbi na kwayoyin halitta, mu bayyana mahimmancin magani na keɓaɓɓen, da samar da albarkatu don nemo manyan likitocin cututtukan daji da wuraren bincike a yankinku.

Fahimtar maye gurbi a cikin Ciwon daji na huhu

Ciwon daji na huhu cuta ce mai rikitarwa, kuma kasancewar takamaiman maye gurbi na kwayoyin halitta yana tasiri sosai dabarun jiyya. Waɗannan maye gurbi suna shafar yadda ƙwayoyin kansa ke girma da kuma amsa hanyoyin kwantar da hankali. Gano takamaiman maye gurbi yana haifar da ciwon huhu na huhu yana da mahimmanci don tsara keɓaɓɓen magani. Maye gurbin gama gari sun haɗa da EGFR, ALK, ROS1, BRAF, da sauransu. Zaɓuɓɓukan magani sun bambanta sosai bisa ga maye gurbin da aka gano. Alal misali, marasa lafiya tare da maye gurbin EGFR na iya amfana daga hanyoyin da aka yi niyya kamar masu hana tyrosine kinase (TKIs).

Nau'o'in Gwajin Kwayoyin Halitta don Ciwon daji na Huhu

Gwajin kwayoyin halitta yana da mahimmanci don tantance takamaiman maye gurbi da ke cikin ƙwayoyin kansar huhu. Wannan yawanci ya ƙunshi biopsy, inda aka bincika ƙaramin samfurin ƙwayar ƙwayar cuta. Akwai hanyoyi da yawa, gami da jerin tsararru na gaba (NGS), waɗanda zasu iya gano ɗimbin sauye-sauyen maye gurbi lokaci guda. Kwararren likitan ku zai jagorance ku ta hanyar gwajin da ya dace kuma ya bayyana sakamakon.

Zaɓuɓɓukan Magani don Ciwon Kanjin Huhu Ta Halitta

Magani ga maye gurbi na huhu ciwon daji sau da yawa ya ƙunshi haɗakar hanyoyin kwantar da hankali waɗanda aka keɓance su da takamaiman maye gurbi. Waɗannan na iya haɗawa da:

Maganin Niyya

Magungunan da aka yi niyya musamman suna yin niyya ne akan ƙananan sunadaran da ƙwayoyin kansa ke samarwa saboda maye gurbi. Waɗannan magungunan galibi suna da tasiri kuma suna da ƙarancin illa fiye da chemotherapy na gargajiya. Misalai sun haɗa da TKIs kamar afatinib, gefitinib, da erlotinib don maye gurbin EGFR, da crizotinib ko alectinib don maye gurbin ALK. Kwararren likitan ku zai taimaka muku fahimtar wane maganin da aka yi niyya ya dace da takamaiman maye gurbin ku.

Immunotherapy

Immunotherapy yana amfani da tsarin garkuwar jikin ku don yaƙar ƙwayoyin cutar kansa. Waɗannan hanyoyin kwantar da hankali na iya yin tasiri musamman a wasu nau'ikan ƙwayoyin cuta na ciwon huhu. Masu hana abubuwan dubawa, irin su pembrolizumab da nivolumab, ana yawan amfani da magungunan rigakafi.

Chemotherapy

Duk da yake an fi son maganin da aka yi niyya da immunotherapy don yawancin maye gurbi na kwayoyin halitta, chemotherapy ya kasance zaɓi mai mahimmanci, musamman a hade tare da wasu jiyya ko don sarrafa ci gaba da cututtuka. Masanin ilimin likitan ku zai ƙayyade tsarin maganin chemotherapy mafi dacewa bisa ga takamaiman yanayin ku.

Radiation Therapy

Maganin radiation yana amfani da radiation mai ƙarfi don kashe ƙwayoyin cutar kansa. Ana amfani da shi sau da yawa a hade tare da wasu jiyya ko don rage alamun bayyanar cututtuka a matakai na gaba.

Neman Kulawa na Musamman kusa da ku don Ciwon daji na huhu

Gano ƙwararrun likitocin oncologists da cibiyoyin jiyya waɗanda suka kware a ciki maye gurbi na huhu ciwon daji yana da mahimmanci. Fara da tuntuɓar likitan ku na farko, wanda zai iya tura ku zuwa likitan oncologist. Hakanan zaka iya bincika kan layi don masu ilimin oncologists da cibiyoyin ciwon daji kusa da ku. Yawancin asibitoci da cibiyoyin bincike sun sadaukar da shirye-shiryen kansar huhu tare da gwaninta a gwajin kwayoyin halitta da keɓaɓɓen magani. Yi la'akari da bincika alaƙa tare da manyan ƙungiyoyin bincike na kansa kamar Cibiyar Ciwon daji ta ƙasa (NCI). The Shandong Baofa Cibiyar Nazarin Ciwon daji babbar cibiya ce da ke ba da ci-gaba jiyya da bincike a kan oncology.

Muhimman La'akari

Bayanin da aka bayar anan don ilimin gabaɗaya ne da dalilai na bayanai kawai, kuma bai ƙunshi shawarar likita ba. Koyaushe tuntuɓi likitan ku ko wasu ƙwararrun ma'aikatan kiwon lafiya tare da kowace tambaya da za ku iya yi game da yanayin likita. Kada ku yi watsi da shawarar likita ko jinkirin neman ta saboda wani abu da kuka karanta akan wannan gidan yanar gizon.

Nau'in maye gurbi Zaɓuɓɓukan Farfaɗo Na Niyya
Farashin EGFR Afatinib, Gefitinib, Erlotinib, Osimertinib
ALK Crizotinib, Alectinib, Brigatinib
ROS1 Crizotinib, Lorlatinib, Entrectinib

Disclaimer: Wannan bayanin an yi shi ne don dalilai na ilimi kawai kuma bai kamata a ɗauki shawarar likita ba. Koyaushe tuntuɓi ƙwararren ƙwararren kiwon lafiya don ganewa da kuma kula da kowane yanayin likita.

Madogararsa: [Saka hanyoyin haɗi zuwa ingantaccen tushe kamar NCI, labaran mujallu masu dacewa, da sauransu, tare da rel=nofollow]

Masu alaƙa samfurori

Samfura masu alaƙa

Mafi kyawun siyarwa samfurori

Mafi kyawun samfuran siyarwa
Gida
Al'amuran Al'ada
Game da Mu
Tuntube Mu

Da fatan za a bar mana sako